Inactive Instrument

Press Releases Otsuka Holdings Co., Ltd. Other OTC

Equities

OTSKY

US6891641010

Press Releases

Unlock all the news: Be the first to know and act before the market!

Otsuka Group Selected for CDP Climate Change a List for a Second Consecutive Year	02-08	AQ
Otsuka Holdings Co., Ltd. - Donations to Support Relief Efforts Following the Noto Peninsula Earthquake	01-10	AQ
Recor Medical Announces U.S. Launch and First Commercial Cases of Paradise Ultrasound Renal Denervation Therapy	11-10	BU
Recor Medical and Otsuka Medical Devices Announce First FDA-Approved Renal Denervation System for the Treatment of Hypertension	11-07	BU
Recor Medical Announces Positive Results from Six-Month Pooled Analysis of Data from the RADIANCE Global Clinical Trial Program at TCT 2023	23-10-26	BU
Recor Medical and Otsuka Medical Devices Announce Positive Vote from U.S. Food and Drug Administration (FDA) Advisory Committee Meeting on the Paradise™ Ultrasound Renal Denervation System for the Treatment of Hypertension	23-08-22	BU
Otsuka : Consolidated Financial Statements for the fiscal year ended December 31, 2022	23-04-27	PU
Otsuka Group Selected for CDP Climate Change A List	22-12-14	AQ
Otsuka Medical Devices and ReCor Medical Announce Submission of Application for Pre-Market Approval of the Paradise Ultrasound Renal Denervation System to the U.S. Food and Drug Administration	22-11-30	AQ
ReCor Medical Announces Consistent Reduction of Blood Pressure in Pooled Analysis of Three Clinical Trials at AHA 2022	22-11-06	BU
Otsuka Medical Devices Announces Results of RADIANCE II Pivotal Trial at TCT 2022 Annual Meeting	22-09-20	AQ
ReCor Medical Announces Results of RADIANCE II Pivotal Trial at TCT 2022 Annual Meeting	22-09-18	BU
ReCor Medical to Present RADIANCE II US Pivotal Trial Data in Late-Breaking Presentation at TCT Conference	22-09-14	BU
Otsuka : Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending December 31, 2022	22-07-29	PU
Otsuka : Notice Regarding Revisions of Consolidated Results Forecast for the first half of FY2022	22-07-26	PU
Otsuka : Medical Devices Announces Primary Endpoint Met in the RADIANCE II US Pivotal Trial of the Paradise System for the Treatment of Hypertension	22-07-26	PU
Otsuka : and Lundbeck announce positive results showing reduced agitation in patients with Alzheimer’s dementia treated with brexpiprazole	22-06-27	PU
Otsuka : Notice Concerning Completion of Payment for Disposal of Treasury Shares as Restricted Stock Compensation	22-04-28	PU
Otsuka : Consolidated Financial Statements for the fiscal year ended December 31, 2021	22-04-21	PU
Otsuka Group Joins RE100 International Initiative - Comitted to 100% Renewable Energy	22-04-21	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Otsuka Holdings Co., Ltd. Other OTC

Equities

OTSKY

US6891641010

Press Releases

Filters